FUSION CI is designed to mine complex multiscale datasets to identify clinical and molecular phenotypes critical to patient profiling and population stratification. FUSION CI can explore your population data utilizing AI-based search techniques to simultaneously test a broad range of candidate intervention sequences for predictive value across multiple clinical parameters, high-complexity assays, and clinical endpoints. FUSION CI onscreen automation options allow research clinicians to rapidly build precision intervention models based on disease category, patient demographics and histopathology, therapeutic schedules, and clinical outcomes utilizing institutional specifications and published EBM guidelines. Discovery reporting includes multivariate assessment of patient characteristics, pathway involvement, and disease associations. FUSION CI can identify promising intervention sequences and perform in silico patient screening without custom programming or costly IT support. FUSION CI is redefining how quickly intervention sequences can be identified, tested, and deployed in the clinical enterprise.